Functional and Neurochemical Brain Changes in First-episode Bipolar Mania
Completed
Conditions studied: Bipolar Disorder
In brief
The purpose of this study is to use magnetic resonance imaging (MRI) to examine brain structure, function and chemistry in people with bipolar disorder who are being treated with either quetiapine or lithium. Both of these medicines are FDA-approved to treat mania in adults and lithium is also FDA approved in children; quetiapine is commonly used in children with mania, but is not FDA approved for this indication in this age group.
Key facts
- Study ID
- NCT00609193
- Run by
- University of Cincinnati
- People needed
- 81
- Starts
- 2008-01-01
- Expected to finish
- 2015-07-01
- Last updated by the study team
- 2015-12-07
Who can join
Age: 12 and older, up to 35. Sex: any. Healthy volunteers: not accepted.
Where it is running
- University of Cincinnati — Cincinnati, Ohio, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.